Clinical trials are research studies involving people that help researchers evaluate medicines, medical devices, procedures, tests, and approaches to care. For a practical introduction to the process, AbbVie clinical trials explains common study types, phases, and participant considerations.
Taking part is a personal decision, whether someone has a medical condition, cares for a potential participant, or is considering volunteering as a healthy adult. A trial may offer an opportunity to contribute to research, but it does not guarantee that a participant will receive a new treatment or experience a better health outcome.
What Clinical Trials Do
Clinical research is different from regular medical care. A healthcare professional’s primary role is to recommend care based on an individual patient’s needs. In research, the team follows a written plan called a protocol to answer specific questions. The results may help guide future healthcare decisions, even when a study treatment does not help an individual participant.
The Main Types Of Clinical Trials
Interventional Studies
In an interventional study, researchers assign participants to receive a treatment, device, procedure, dose, or care plan and track the results. Some studies compare an investigational option with standard care, another active treatment, or a placebo.
Observational Studies
Observational studies collect health information without assigning a new intervention. Researchers might monitor symptoms, lifestyle patterns, treatment experiences, or health outcomes during normal care.
Other Study Designs To Know
A study may be randomized, meaning assignment to groups is determined by chance. It may be open-label, meaning participants and researchers know the assigned treatment, or it may involve masking. Studies can take place at one site or many sites. Some also use remote check-ins, local testing, or home-based services when the protocol allows.
How Clinical Trial Phases Work
Many studies of investigational drugs move through phases, although the exact design varies by treatment and medical area.
- Phase I: Examines early safety, tolerability, dosage, and how the body processes an intervention.
- Phase II: Explores possible benefits in a larger group while continuing to monitor safety and side effects.
- Phase III: Often compares the intervention with standard care, placebo, or another option in more participants.
- Phase IV: May gather additional information after approval, including longer-term safety and real-world use.
Safety Protections For Participants
Before enrollment, participants review informed consent materials that explain the study’s purpose, procedures, possible risks, potential benefits, and alternatives. Consent is an ongoing conversation, not simply a signature. Ethics committees or institutional review boards review research plans, and study teams monitor participants for side effects or other health changes.
Participation is voluntary. A participant should ask how leaving the study could affect follow-up care, and should report new symptoms promptly. The informed consent process is intended to support a voluntary, understandable decision rather than pressure someone to enroll.
Who May Qualify For A Trial?
Every protocol has eligibility criteria. These may include age, diagnosis, symptoms, prior treatments, current medicines, overall health, laboratory findings, imaging results, location, and ability to attend visits. Not qualifying for one study does not mean someone cannot qualify for another. No one should stop taking a medication or change a treatment plan to meet study requirements without advice from a qualified healthcare professional.
What Participants Can Expect
The process commonly begins with identifying a relevant study, followed by a pre-screening discussion. If there appears to be a match, the participant reviews the consent materials and completes the screening assessments. Eligible participants then follow the study schedule, which may include clinic visits, calls, remote check-ins, surveys, blood tests, imaging, or symptom reporting. Follow-up may continue after the main treatment period ends.
Questions To Ask Before Joining
- What is the study trying to learn, and what phase is it in?
- What treatments, procedures, tests, or visits are involved?
- Could I receive a placebo, standard care, or a different dose?
- How long will participation last, and are remote visits possible?
- What side effects, risks, and inconveniences are known or possible?
- Which costs are covered, and which may involve me or my insurer?
- Who can I contact after hours or if I develop symptoms?
- What happens if I decide to leave or if the study ends early?
Potential Benefits And Possible Risks
Possible benefits can include closer contact with a research team, access to an investigational approach, and the opportunity to contribute to knowledge that may help others. However, a study treatment may not work, may cause side effects, or may prove less effective than existing care. Participants may also face extra appointments, tests, travel, time away from work, or changes to daily routines. A clinical trial is one option to discuss, not a promise or a substitute for informed medical advice.
Why Access And Inclusion Matter
Research is stronger when participants represent varied ages, backgrounds, locations, and health histories. Barriers can include travel distance, work and caregiving responsibilities, language differences, limited internet access, cost concerns, lack of awareness, and distrust arising from poor communication or past harm. Asking about transportation, scheduling flexibility, translated materials, and remote options can help people understand whether participation is realistic.
A Simple Pre-Enrollment Checklist
- Read the consent form more than once and write down questions.
- Discuss the study with a regular healthcare professional.
- Bring a trusted person to the conversation if permitted.
- Review visit frequency, travel needs, and potential routine care costs.
- Keep a current list of medicines, symptoms, and appointments.
- Do not feel pressured to make an immediate decision.
Common Questions
Can A Person Leave A Clinical Trial?
Participants can ask the study team about withdrawal procedures and any safety follow-up that may be recommended after leaving the study.
Can Healthy People Join?
Yes. Some studies require healthy volunteers to assess safety, normal physiology, or the body’s response to an intervention.
Where Can Someone Find A Study?
People can speak with their healthcare professional, search public listings such as registered clinical studies, and then review eligibility details with the research team.
Clinical trial participation should always be an informed choice, made without pressure and with a clear understanding of what is involved. Start by reviewing the study protocol, including its purpose, procedures, schedule, and possible risks and benefits. Consider the time commitment, travel, and uncertainties, since outcomes are not guaranteed. Ask direct questions about costs, side effects, and the right to withdraw at any time. Finally, consult a trusted healthcare professional who knows your history. Together, these steps can help a person decide whether a particular study fits their needs.
